Friday, December 12, 2014 11:20:34 AM
I was hoping we'd reach the 7s beforeyearend,
but now I think we'll be lucky to hold the 6s.
What a nice presentation yesterday.
KM is kinda flat on camera though.
He speaks too fast, because he's trying to
say too much, because he knows time will be
short. And he knows what he's likely to be asked,
and his answers come across as memorized and
canned, instead of conversational and inspired.
He also needs to stop doing that weird thing
with his eyes.
And the haircut speaks for itself.
All in all though, His presentation was impressive.
Because the product is so impressive.
I was kind of dumbstruck by the comments by the
panelists. It was as if KMs words hit their ears and
simply bounced off. KM described the 15x15 printed
liver device, and all he got was four dumb looks as if
these people had just been told, the sky is blue.
The dingy-blonde girl looks almost retarded. The
yo-Adrien guy on the right wasn't bad.
If the general public is as mentally flat-footed as those
panelists, that would explain the share price.
but now I think we'll be lucky to hold the 6s.
What a nice presentation yesterday.
KM is kinda flat on camera though.
He speaks too fast, because he's trying to
say too much, because he knows time will be
short. And he knows what he's likely to be asked,
and his answers come across as memorized and
canned, instead of conversational and inspired.
He also needs to stop doing that weird thing
with his eyes.
And the haircut speaks for itself.
All in all though, His presentation was impressive.
Because the product is so impressive.
I was kind of dumbstruck by the comments by the
panelists. It was as if KMs words hit their ears and
simply bounced off. KM described the 15x15 printed
liver device, and all he got was four dumb looks as if
these people had just been told, the sky is blue.
The dingy-blonde girl looks almost retarded. The
yo-Adrien guy on the right wasn't bad.
If the general public is as mentally flat-footed as those
panelists, that would explain the share price.
Recent VIVS News
- VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing • GlobeNewswire Inc. • 04/28/2026 12:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/06/2026 05:27:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:10 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 04/02/2026 08:00:55 PM
- VivoSim Announces Pricing of up to a $4 Million Public Offering • GlobeNewswire Inc. • 04/01/2026 12:05:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/31/2026 02:17:06 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/27/2026 09:26:52 PM
- VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs • GlobeNewswire Inc. • 03/24/2026 12:05:00 PM
- VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales • GlobeNewswire Inc. • 03/03/2026 01:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 09:05:26 PM
- VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego • GlobeNewswire Inc. • 02/11/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:59:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:51:43 AM
- VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China • GlobeNewswire Inc. • 01/29/2026 09:05:00 PM
- VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer • GlobeNewswire Inc. • 01/06/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:05:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2025 11:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:08:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2025 09:07:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/03/2025 09:06:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/28/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2025 12:45:18 AM
